SIA
PFE icon

Stancorp Investment Advisers’s Pfizer PFE Stock Holding History

Stancorp Investment Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$633K Sell
19,187
-30
-0.2% -$954 0.3% 95
2014
Q4 		$568K Buy
+19,217
New +$551K 0.26% 111

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stancorp Investment Advisers's PFE Position: Q1 2015 in Review

Stancorp Investment Advisers reduced its Pfizer (PFE) stake by 0.16% in Q1 2015, selling an estimated $954 and leaving 19,187 shares worth $633K. The position accounts for 0.3% of the portfolio, ranked #95.

Stancorp Investment Advisers first reported a position in PFE in Q4 2014 and has held it in 2 quarters since. 1,875 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

  • Stancorp Investment Advisers held 19,187 shares of Pfizer worth $633K as of Q1 2015.
  • Stancorp Investment Advisers sold 30 Pfizer shares in Q1 2015, an estimated $954.
  • Pfizer made up 0.3% of Stancorp Investment Advisers's portfolio in Q1 2015, its #95 holding.
  • Stancorp Investment Advisers first reported a position in Pfizer in Q4 2014 and has held it in 2 quarters since.
  • 1,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Stancorp Investment Advisers's 13F filing for Q1 2015, filed 13 May 2015.